Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies

Federico Cappuzzo, Ross Soo, Maximilian Hochmair, Martin Schuler, Kwok Chi Lam, Gerd Stehle, Agnieszka Cseh, Robert M Lorence, Stephan Linden, Nicole D Forman, Wolfgang Hilbe, Abdul Rahman Jazieh, Chun-Ming Tsai
  • Future Oncology, June 2018, Future Medicine
  • DOI: 10.2217/fon-2017-0666

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2217/fon-2017-0666

The following have contributed to this page: Dr Federico Cappuzzo